You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Jakavi

Showing 26 - 41 of 41
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Haemophagocytic Lymphohistiocytosis Trial (Ruxolitinib)

Not yet recruiting
  • Haemophagocytic Lymphohistiocytosis
  • (no location specified)
Feb 28, 2023

Polycythemia Vera (PV), Essential Thrombocythemia (ET) Trial in Germany (Ruxolitinib, BAT)

Active, not recruiting
  • Polycythemia Vera (PV)
  • Essential Thrombocythemia (ET)
  • Mannheim, Baden-Württemberg, Germany
  • +23 more
Oct 6, 2020

Alopecia Areata Trial in New York (Ruxolitinib)

Completed
Has Results
  • Alopecia Areata
  • New York, New York
    Columbia University Medical Center, Department of Dermatology
Apr 15, 2019

Myelofibrosis Trial in Worldwide (PIM447, Ruxolitinib, LEE011)

Completed
  • Myelofibrosis
  • VIC, Melbourne, Australia
  • +8 more
Feb 7, 2022

Accelerated/Blast-phase Myeloproliferative Tumor, Chronic-phase Myelofibrosis, IDH2 Mutation Trial in Canada, United States

Recruiting
  • Accelerated/Blast-phase Myeloproliferative Neoplasm
  • +2 more
  • Scottsdale, Arizona
  • +10 more
May 9, 2022

Myelofibrosis, Primary Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis Trial in Worldwide (parsaclisib, ruxolitinib,

Recruiting
  • Myelofibrosis
  • +3 more
  • Anchorage, Alaska
  • +172 more
Dec 1, 2022

Myelofibrosis, Primary Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis Trial in Worldwide (parsaclisib, ruxolitinib,

Recruiting
  • Myelofibrosis
  • +3 more
  • Berkeley, California
  • +176 more
Dec 1, 2022

ARDS, Human, COVID Trial in Marburg (Ruxolitinib administration)

Completed
  • ARDS, Human
  • COVID
  • Ruxolitinib administration
  • Marburg, Germany
    Andreas Neubauer
Aug 23, 2021

Relapsed or Refractory Hodgkin Lymphoma, Primary Mediastinal Large B-cell Lymphoma Trial in Busan, Seoul, Wonju (Ruxolitinib)

Completed
  • Relapsed or Refractory Hodgkin Lymphoma
  • Primary Mediastinal Large B-cell Lymphoma
  • Busan, Korea, Republic of
  • +6 more
Oct 30, 2018

Hodgkin's Lymphoma Trial in Belgium, France (Ruxolitinib)

Completed
  • Hodgkin's Lymphoma
  • Brussels, Belgium
  • +9 more
Aug 21, 2018

NSCLC (Non-small Cell Lung Carcinoma) Trial in United States (Ruxolitinib, Placebo, Pemetrexed)

Terminated
Has Results
  • NSCLC (Non-small Cell Lung Carcinoma)
  • Phoenix, Arizona
  • +29 more
Jan 15, 2018

Pancreatic Cancer Trial in Worldwide (Ruxolitinib, Placebo, Capecitabine)

Terminated
Has Results
  • Pancreatic Cancer
  • Avondale, Arizona
  • +229 more
Mar 14, 2019

CRC (Colorectal Cancer) Trial in Worldwide (Ruxolitinib, Regorafenib, Placebo)

Terminated
Has Results
  • CRC (Colorectal Cancer)
  • Chandler, Arizona
  • +85 more
Jan 15, 2018

Pancreatic Cancer Trial in Worldwide (Ruxolitinib, Placebo, Capecitabine)

Terminated
Has Results
  • Pancreatic Cancer
  • Huntsville, Alabama
  • +94 more
Jan 15, 2018

Breast Cancer Trial in Worldwide (Ruxolitinib, Capecitabine, Placebo)

Terminated
Has Results
  • Breast Cancer
  • Birmingham, Alabama
  • +106 more
Jan 15, 2018

Primary Myelofibrosis Trial in Leipzig, Firenze, Madrid (Ruxolitinib)

Terminated
Has Results
  • Primary Myelofibrosis
  • Leipzig, Germany
  • +2 more
Feb 24, 2016